Ascendis Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 13:06:02 ET ASND

Published on 05/07/2026 at 01:06 pm EDT

Ascendis Pharma A/S reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was EUR 246.6 million compared to EUR 100.95 million a year ago. Net income was EUR 629.34 million compared to net loss of EUR 94.63 million a year ago.

Basic earnings per share from continuing operations was EUR 10.2 compared to basic loss per share from continuing operations of EUR 1.58 a year ago. Diluted earnings per share from continuing operations was EUR 9.75 compared to diluted loss per share from continuing operations of EUR 1.58 a year ago.